Johnson & Johnson’s COVID-19 vaccine, a single-shot alternative to other pharmaceutical companies’ two-dose series, is “no longer available” in the United States, health officials said.
The last of the government’s J&J vaccine stock expired May 7, according to the Centers for Disease Control and Prevention.
“Dispose of any remaining Janssen COVID-19 Vacci…
